dc.contributor.author | HERGENÇ, Gülay | |
dc.contributor.author | Can, Günay | |
dc.contributor.author | NARTOP, Filiz | |
dc.contributor.author | UGUR, Murat | |
dc.contributor.author | ONAT, Altan | |
dc.date.accessioned | 2021-03-05T13:11:13Z | |
dc.date.available | 2021-03-05T13:11:13Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | ONAT A., HERGENÇ G., Can G., UGUR M., NARTOP F., "Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk", CLINICAL CHEMISTRY AND LABORATORY MEDICINE, cilt.49, ss.1349-1357, 2011 | |
dc.identifier.issn | 1434-6621 | |
dc.identifier.other | av_b0fff58f-99c2-4d8a-a42b-1b97b93f0bd3 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/117944 | |
dc.identifier.uri | https://doi.org/10.1515/cclm.2011.110 | |
dc.description.abstract | Background: The clinical relevance of serum lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in populations prone to cardiometabolic risk needs exploration. We determined major covariates of Lp-PLA(2) mass, and its associations with cardiometabolic disorders. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Sağlık Bilimleri | |
dc.subject | TIBBİ LABORATUVAR TEKNOLOJİSİ | |
dc.subject | Klinik Tıp | |
dc.subject | Tıp | |
dc.title | Dual activity of serum lipoprotein-associated phospholipase A(2) yielding positive and inverse associations with cardiometabolic risk | |
dc.type | Makale | |
dc.relation.journal | CLINICAL CHEMISTRY AND LABORATORY MEDICINE | |
dc.contributor.department | Turkish Heart Foundation , , | |
dc.identifier.volume | 49 | |
dc.identifier.issue | 8 | |
dc.identifier.startpage | 1349 | |
dc.identifier.endpage | 1357 | |
dc.contributor.firstauthorID | 90764 | |